← SynDRA
ZAMICASTAT
SynDRA canonical compound SYN0040065 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | DBH |
| Mechanism of action | dopamine beta hydroxylase inhibitor |
| Indication | pulmonary arterial hypertension (pah) |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- DBH INHIBITOR
- Dopamine beta-hydroxylase inhibitor
- dopamine beta hydroxylase inhibitor
Drug classes
Cross-references
Synonyms
- YLU32D0DNV
- zamicastatum
- RefChem:907109
- DTXCID2070849
- Zamicastat [INN]
- UNII-YLU32D0DNV
- orb1308925
- SCHEMBL2832423
- SCHEMBL9953350
- SCHEMBL29409449
- ZSSLCFLHEFXANG-GOSISDBHSA-N
- EX-A3318
- AKOS040740601
- BIA 5-1058
- AC-35653
- DA-79068
- MS-26837
- HY-106004
- CS-0024612
- NS00072549
- G14497
- T13383
- RefChem:195840
- OIXMDJZVHVPBNM-GMUIIQOCSA-N
- SCHEMBL9959214
- DTXCID8083143
- zamicastat hydrochloride
- PXQ9G79I10
- Zamicastat hydrochloride
- UNII-PXQ9G79I10
Look up ZAMICASTAT in the interactive SynDRA portal →